-
Jul 23, 2015, 12:00 PM
by
Michael Croft
Bio-IT World Contributed Commentary | The European Medicines Agency (EMA) has mandated that all life sciences organizations in Europe and those selling products in Europe demonstrate compliance with the Identification of Medicinal Products (IDMP) standards by July 1, 2016. It’s now imperative for IT and business groups to begin formulating a strategy to not just comply with IDMP, but to embrace it as an impetus for change within the organization.
Full story
-
Jul 23, 2015, 00:00 AM
by
Michael Croft
Computerworld | Google on Thursday had its sights
fixed firmly on Amazon as it launched its new, low-cost Nearline
cloud storage service out of beta and into general availability.
Full story
-
Jul 22, 2015, 13:00 PM
by
Michael Croft
Bio-IT World | 23andMe today shut down an app built with its API that purported to enable web developers to “restrict access to your site based on traits including sex, ancestry, disease susceptibility [stet], and arbitrary characteristics associated with single-nucleotide polymorphisms (SNPs) in a person's genotype.”
Full story
-
Jul 22, 2015, 00:00 AM
by
Michael Croft
Washington Post | A painful chapter in his life
motivates a researcher to bring deep learning to genomics.
Full story
-
Jul 21, 2015, 12:15 PM
by
Michael Croft
Bio-IT World News Brief | Oxford Nanopore Technologies announced today that it has raised an additional $109 million in funding for product development and to ramp up manufacturing, coinciding with open applications to join an early access program for the company's first high-throughput instrument.
Full story
-
Jul 21, 2015, 11:00 AM
by
Michael Croft
Bio-IT World | AncestryDNA and Google’s Calico today announced an effort to investigate human heredity of lifespan. The two will analyze and investigate the role of genetics and its influences in families experiencing unusual longevity using Ancestry’s proprietary databases, tools and algorithms. Calico will then focus its efforts to develop and commercialize any potential therapeutics that emerge from the analysis.
Full story
-
Jul 20, 2015, 00:00 AM
by
Michael Croft
NEW YORK, NY - Jul 20, 2015 - Creative Bioarray, an innovative biotechnology company who supplies research-use cells, cell culture medium and reagents, FISH probes, tissue array, microorganisms, equipments and related services, etc, has announced its Whole Chromosome Painting Probes to bio-research community
Full story
-
Jul 16, 2015, 11:10 AM
by
Michael Croft
Bio-IT World | After receiving FDA clearance for a single carrier screening test this February, 23andMe has promised to release a new health product to its customers later this year. But regulations are sure to change the types of genetic tests available on the direct-to-consumer market — and lead some to look for alternative ways to expand public access to useful genomic information.
Full story
-
Jul 15, 2015, 00:00 AM
by
Michael Croft
CHORLEY, UNITED KINGDOM - Jul 15, 2015 - Synexus continues to expand across Eastern Europe with three new Dedicated Research Centres in Bulgaria, Poland and Romania, bringing the total to nine centres in Eastern Europe and a total network of 25 across Europe and Africa
Full story
-
Jul 15, 2015, 00:00 AM
by
Michael Croft
LUND, SWEDEN - Jul 15, 2015 - ~~Qlucore announces 3 year
license from Europe's largest biopharmaceutical company
Software to help Actelion visualize and analyze "big data"
Qlucore, a world leader in the development of bioinformatics
software, has announced a three year license contract with
Actelion, one of Europe's leading biopharmaceutical companies
Full story
-
Jul 15, 2015, 00:00 AM
by
Michael Croft
HARDERWIJK, NETHERLANDS - Jul 15, 2015 - Today, molecular
genetics Ag Biotech company KeyGene and biomedical big data
solutions company GENALICE, jointly mark the significant mutual
benefits of their first two years of partnerships, running GENALICE
MAP in full production as their preferred tool for primary
Next-Generation Sequencing (NGS) data analysis
Full story
-
Jul 15, 2015, 00:00 AM
by
Michael Croft
Forbes | Matthew Herper talks to Elizabeth Holmes
and the organizations partnering with her company Theranos, to
check out the evidence for her claims to radically reduce the price
and burden of blood tests.
Full story
-
Jul 14, 2015, 15:00 PM
by
Michael Croft
Bio-IT World News Brief | The Paul G. Allen Family Foundation announced five Allen Distinguished Investigator (ADI) grants to teams of researchers with projects that will open new and innovative avenues of research in Alzheimer’s disease. The projects are funded at a total of $7 million over three years.
Full story
-
Jul 14, 2015, 00:00 AM
by
Michael Croft
GeekWire | Lee Hood's new startup, Arivale, raised
$36 million yesterday from Arch Venture Partners and Polaris
Partners. The company's total funding is now at $40 million.
Full story
-
Jul 14, 2015, 00:00 AM
by
Michael Croft
ROCHESTER, NY, UNITED STATES - Jul 14, 2015 - The latest iteration of Clinical Conductor CTMScontinues the proven strategy of providing research organizations with the most in-depth features and functionality available, further distancing the application from others in the industry, which fail to provide the tools necessary for truly complete clinical research management
Full story
-
Jul 14, 2015, 00:00 AM
by
Michael Croft
CNET | Two supercomputing centers of excellence
revolve around making sure applications can take advantage of
compute horsepower and gathering feedback from developers,
engineers and scientists.
Full story
-
Jul 14, 2015, 00:00 AM
by
Michael Croft
SAN DIEGO, CA, UNITED STATES - Jul 14, 2015 - Rancho BioSciences, the Data Curation Company, today announced that they will work with BT to provide cloud-based data curation services to their joint customers
Full story
-
Jul 14, 2015, 00:00 AM
by
Michael Croft
LENEXA, KS, UNITED STATES - Jul 14, 2015 - Contract Research Organization XenoTech, LLC, a division of Sekisui, announces the addition of in vitro toxicology to its global drug development service portfolio
Full story
-
Jul 10, 2015, 00:00 AM
by
Michael Croft
Xconomy | The U.S. House of Representatives took a
big step this morning toward major changes in the federal
government's relationship to biomedical research, funding and
regulation.
Full story
-
Jul 10, 2015, 00:00 AM
by
Michael Croft
Xconomy | Juno Therapeutics has built remarkable
momentum and is about to launch the first trial in humans of
engineered T cells.
Full story